Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Glucocorticoid administration to mice results in a rapid loss of bone mineral density due to an imbalance in osteoblast and osteoclast numbers. Whereas excess glucocorticoids reduce both osteoblast and osteoclast precursors, cancellous osteoclast number surprisingly does not decrease as does osteoblast number, presumably due to the ability of glucocorticoids to promote osteoclast life span. Whether glucocorticoids act directly on osteoclasts in vivo to promote their life span and whether this contributes to the rapid loss of bone with glucocorticoid excess remains unknown. To determine the direct effects of glucocorticoids on osteoclasts in vivo, we expressed 11β-hydroxysteroid dehydrogenase type 2, an enzyme that inactivates glucocorticoids, specifically in the osteoclasts of transgenic mice using the tartrate-resistant acid phosphatase promoter. Bone mass, geometry, and histomorphometry were similar in untreated wild-type and transgenic animals. Glucocorticoid administration for 7 d caused equivalent increases in cancellous osteoblast apoptosis, and equivalent decreases in osteoblasts, osteoid, and bone formation, in wild-type and transgenic mice. In contrast, glucocorticoids stimulated expression of the mRNA for calcitonin receptor, an osteoclast product, in wild-type but not transgenic mice. Consistent with the previous finding that glucocorticoids decrease osteoclast precursors and prolong osteoclast life span, glucocorticoids decreased cancellous osteoclast number in the transgenic mice but not wild-type mice. In accord with this decrease in osteoclast number, the loss of bone density observed in wild-type mice was strikingly prevented in transgenic mice. These results demonstrate for the first time that the early, rapid loss of bone caused by glucocorticoid excess results from direct actions on osteoclasts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A high level of glucocorticoid in smokers alters bone metabolism and decreases bone mass either directly by changing the osteoblast and osteoclast activities or indirectly by altering the gastrointestinal absorption and renal reabsorption of calcium [39–42].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [40]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 24 · Cited by 394
Metadata
- Authors
- Jia, D., O’Brien, C. A., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S.
- Affiliations
- Central Arkansas Veterans Healthcare System (US)
- Corresponding author
- Jia, D.
- O’Brien, C. A.
- Weinstein, R. S.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-12-01
- Volume
- 147
- Issue
- 12
- Pages
- 5592-5599
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC1819400
- OpenAlex
- W2011629184
- Cited by
- 394
- References
- 24
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 14 · 2023: 27 · 2022: 23 · 2021: 28 · 2020: 17 · 2019: 28 · 2018: 27 · 2017: 23 · 2016: 22 · 2015: 16 · 2014: 17 · 2013: 19 · 2012: 29
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000436)
- Office of Research and Development
- University of Arkansas for Medical Sciences
- National Institutes of Health (AG13918)
- National Institute on Aging (P01AG013918)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR046191, R01AR049794)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoids, osteoclasts, bone mineral loss, 11β-hydroxysteroid dehydrogenase type 2, glucocorticoid inactivation, osteoclast precursors, osteoblast apoptosis, calcitonin receptor, glucocorticoid-induced osteoporosis, transgenic mice, bone formation
- MeSH terms
- Animals, Bone and Bones, Bone Development, Dexamethasone, Female, Glucocorticoids, Male, Mice, Transgenic, Organ Specificity, Osteoclasts, Prednisolone, Spine, Bone Density, Transgenes, 11-beta-Hydroxysteroid Dehydrogenase Type 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density. https://app.cochat.ai/papers/10.1210/en.2006-0459
- The paper
- Jia, D., O’Brien, C. A., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2006). Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density. Endocrinology. https://doi.org/10.1210/en.2006-0459
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.